QB3 logo

QB3

North America, California, United States, San Francisco

Description

California Institute for Quantitative Biosciences is a group of research institutes created for the benefit of the bioeconomical society.

Investor Profile

QB3 has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series Unknown (33%)
  • Series B (33%)
  • Grant (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Bioinformatics
  • Genetics
  • Oncology
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Apps
  • Consumer
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does QB3 frequently co-invest with?

Foothill Ventures
North America, California, United States, Los Altos
Co-Investments: 1
Genoa Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Keiretsu Capital
North America, Washington, United States, Seattle
Co-Investments: 1
Fusion Fund
North America, California, United States, Palo Alto
Co-Investments: 1
Green Park & Golf Ventures
North America, Texas, United States, Dallas
Co-Investments: 1
Chan Zuckerberg Initiative
North America, California, United States, Palo Alto
Co-Investments: 1
Keiretsu Forum
North America, California, United States, Orinda
Co-Investments: 1
Cota Capital
North America, California, United States, San Francisco
Co-Investments: 1
JLABS
North America, California, United States, San Diego
Co-Investments: 2
Alumni Ventures
North America, New Hampshire, United States, Manchester
Co-Investments: 1

Which angels does QB3 often collaborate with?

SH
North America, North Carolina, United States, Raleigh
Shared Deals: 1
JF
North America, California, United States
Shared Deals: 1

What are some of recent deals done by QB3?

Mission Bio

San Francisco, California, United States

Mission Bio develops only single-cell multi-omics platform integrating genotype and phenotype for cancer research and biomarker development.

BioinformaticsBiotechnologyGeneticsHealth CareOncology
Series UnknownJun 29, 2018
Pionyr Immunotherapeutics

South San Francisco, California, United States

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BDec 13, 2017
Amount Raised: $62,000,000
Lioness

Berkeley, California, United States

Destigmatizing women's sexual health through information and conversation.

AppsConsumerEducationHealth CareLifestyleSex TechSoftwareWomen's
GrantMar 9, 2014